<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22865" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>High Altitude Oxygenation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mathew</surname>
            <given-names>Tripthi M.</given-names>
          </name>
          <aff>Alpha &#x00026; Omega Healthcare Management Cons</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Mery Fitzgerald Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tripthi Mathew declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22865.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">High altitude oxygenation is improving oxygenation or enriching the body with additional oxygen at high altitudes.<xref ref-type="bibr" rid="article-22865.r1">[1]</xref></p>
        <p>According to the Society of Mountain Medicine (Effects of high altitude on humans), there are three altitude regions:</p>
        <list list-type="bullet">
          <list-item>
            <p>High altitude = 1500 to 3500 meters above sea level (4900-11500 ft.)</p>
          </list-item>
          <list-item>
            <p>Very high altitude = 3500 to 5500 meters above sea level (11500 to 18000 ft.)</p>
          </list-item>
          <list-item>
            <p>Extreme altitude = above 5500 meters above sea level (18000 ft.)</p>
          </list-item>
        </list>
        <p>Mount Everest, the highest mountain on earth, is at 29029 feet above sea level. It is in the extreme altitude region. These three altitude regions correspond with different levels of low oxygen in the atmosphere. At Mount Everest, the atmospheric pressure is around 228 mmHg, but the percent of fraction of inspired oxygen is the same as sea level, where the atmospheric pressure is 760 mmHg.</p>
      </sec>
      <sec id="article-22865.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>In addition to pilots, crew, and passengers of aircraft, athletes, travelers (lowlanders) to ski resorts, mountaineering expeditions, and people going on pilgrimage to monasteries, abbeys, shrines, or temples are at high risk for developing acute mountain sickness or high altitude illness. If untreated, it can lead to its severe manifestations: high&#x02013;altitude pulmonary edema (HAPE) and high-altitude cerebral edema (HACE). &#x000a0;High altitude oxygenation can help such people or those accompanying them acclimatize to high altitudes, hence preventing or ameliorating the symptoms of high altitude illness and/or the progression to severe illnesses. An altitude generator can help acclimatize to high altitudes in a bedroom by producing varying oxygen levels depending on the altitude level one plans to ascend. For example, it can generate 20.9% oxygen at sea level to 9.5% oxygen at 20000 feet (6000 meters) above sea level.&#x000a0;</p>
      </sec>
      <sec id="article-22865.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>High altitudes can cause low oxygen saturation levels or desaturation of an individual's blood. It happens because of low atmospheric pressure at high altitudes. Oxygen saturation levels refer to the extent hemoglobin is bound or saturated to oxygen.&#x000a0; A small device called a pulse oximeter (image 1) measures the oxygen saturation level and pulse/HR. This device is typically used on the index finger. Normal oxygen saturation levels are 95% to 100%.&#x000a0; Oxygen saturation levels below 90% are considered abnormal.</p>
        <p>Some symptoms of low oxygen saturation levels include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Shortness of breath</p>
          </list-item>
          <list-item>
            <p>Cyanosis</p>
          </list-item>
          <list-item>
            <p>Extreme fatigue and weakness</p>
          </list-item>
          <list-item>
            <p>Mental confusion</p>
          </list-item>
          <list-item>
            <p>Headaches</p>
          </list-item>
        </list>
        <p>Other causes of low oxygen saturation levels include blood hypoventilation (OSA and oversedation), V/Q mismatch - pulmonary embolism,&#x000a0; airway obstruction (chronic obstructive pulmonary disease or COPD and sleep apnea), diffusion abnormalities (pneumonia, CHF, alveolar hemorrhage, emphysema, interstitial lung disease (ILD), acute respiratory distress syndrome (ARDS), and shunts (intra- and extra-pulmonary).&#x000a0;</p>
        <p>Blood oxygen saturation levels cannot go above 100%. It is not possible to achieve 100% oxygen saturation levels breathing room air. The only way to accomplish this is by breathing oxygen through medical devices (masks, Gamow bags, and tents) or homes with oxygen-controlled rooms like in some mountain homes in Colorado and other mountainous regions. Portable hyperbaric chambers are also used at high altitudes, especially during emergencies <xref ref-type="bibr" rid="article-22865.r2">[2]</xref>.&#x000a0;</p>
        <p>However, inhaling oxygen for a long time can cause adverse effects.&#x000a0; These include retinopathy and blindness. Studies have indicated changes in corneal thickness in patients with high&#x02013;altitude pulmonary edema after systemic oxygen therapy.<xref ref-type="bibr" rid="article-22865.r3">[3]</xref></p>
        <p>Recent epidemiological studies suggest that taking coco-flavanol for a week increases prefrontal cortex oxygenation at rest and during moderate-intensity exercise in normoxia and hypoxia.<xref ref-type="bibr" rid="article-22865.r4">[4]</xref></p>
        <p>Drugs are also used in the prevention and treatment of high-altitude illnesses. Some of these can improve oxygenation. Acetazolamide is the most common drug used to prevent high-altitude illness.<xref ref-type="bibr" rid="article-22865.r5">[5]</xref> Studies have shown that benzolamide improves oxygenation, reduces acute mountain sickness, and has fewer side effects than acetazolamide.<xref ref-type="bibr" rid="article-22865.r6">[6]</xref></p>
        <p>Other studies demonstrate the effectiveness of dexamethasone in improving pulmonary hemodynamics in patients with COPD going to altitudes.<xref ref-type="bibr" rid="article-22865.r7">[7]</xref></p>
      </sec>
      <sec id="article-22865.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22865&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22865">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22865/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22865">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22865.s5">
        <fig id="article-22865.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pulse Oximeter. An image of a pulse oximeter showing 98% oxygen saturation level and a heart rate of 52 bpm. Contributed by TM Mathew, MD, MPH, MBA, PhD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Pulse__Oximeter__submitted__by__Dr.__Tripthi__Mathew" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22865.s6">
        <title>References</title>
        <ref id="article-22865.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>West</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Improving oxygenation at high altitude: acclimatization and O2 enrichment.</article-title>
            <source>High Alt Med Biol</source>
            <year>2003</year>
            <season>Fall</season>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-98</page-range>
            <pub-id pub-id-type="pmid">14561244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22865.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flaherty</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Under pressure: facilitating the emergency use of portable hyperbaric chambers at altitude.</article-title>
            <source>Travel Med Infect Dis</source>
            <year>2014</year>
            <season>Sep-Oct</season>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>420</fpage>
            <page-range>420-1</page-range>
            <pub-id pub-id-type="pmid">25246227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22865.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patyal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kotwal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Changes in corneal thickness in patients with high-altitude pulmonary edema after systemic oxygen therapy.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>11</issue>
            <fpage>1554</fpage>
            <page-range>1554-1557</page-range>
            <pub-id pub-id-type="pmid">30355859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22865.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Decroix</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tonoli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lespagnol</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Balestra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Descat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Drittij-Reijnders</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Stahl</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Weseler</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bast</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meeusen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heyman</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>One-week cocoa flavanol intake increases prefrontal cortex oxygenation at rest and during moderate-intensity exercise in normoxia and hypoxia.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>2018</year>
            <month>Jul</month>
            <day>01</day>
            <volume>125</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-18</page-range>
            <pub-id pub-id-type="pmid">29543135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22865.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burtscher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gatterer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Faulhaber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burtscher</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acetazolamide pre-treatment before ascending to high altitudes: when to start?</article-title>
            <source>Int J Clin Exp Med</source>
            <year>2014</year>
            <volume>7</volume>
            <issue>11</issue>
            <fpage>4378</fpage>
            <page-range>4378-83</page-range>
            <pub-id pub-id-type="pmid">25550957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22865.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collier</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Hedges</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Nathan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Flower</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Milledge</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Swenson</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Benzolamide improves oxygenation and reduces acute mountain sickness during a high-altitude trek and has fewer side effects than acetazolamide at sea level.</article-title>
            <source>Pharmacol Res Perspect</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>e00203</fpage>
            <pub-id pub-id-type="pmid">27433337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22865.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lichtblau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Furian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aeschbacher</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Bisang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ulrich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saxer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sheraliev</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Marazhapov</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Osmonov</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Estebesova</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sooronbaev</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Ulrich</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Dexamethasone improves pulmonary hemodynamics in COPD-patients going to altitude: A randomized trial.</article-title>
            <source>Int J Cardiol</source>
            <year>2019</year>
            <month>May</month>
            <day>15</day>
            <volume>283</volume>
            <fpage>159</fpage>
            <page-range>159-164</page-range>
            <pub-id pub-id-type="pmid">30638985</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
